The drugs industry is an enormous multibillion businesses encompassing an immense number of companies involved in the design, production and marketing of drugs worldwide. According to the type of drugs the market can be dived into the following segments: diabetes, antifungal, antidepressant, antithrombotic, hepatitis drugs, analgesics and a far more.
Currently, the drugs market is undergoing a recovery phase in the wake of the recent decline provoked by the economic slump. The market growth is spurred by increasing demand for drugs across the globe, rising incidence of chronic as well as infectious diseases, population ageing, product innovations and constant technological advancements. North America and Europe are the most prominent regional markets. Bristol-Myers Squibb, Pharmacia, GlaxoSmithKline, Merck & Co, Novartis, Eli Lilly, Pfizer, Johnson & Johnson, Allergan, Schering-Plough, Bayer and Abbott Labs are amid global drugs arena giants.
A huge collection of the research reports covering the drugs market at different geographies can be found under this MarketPublishers’ catalogue. The researches provide comprehensive assessment of the market, characterize major market trends and disclose essential market indicators. The reports describe the competitive scenario and indicate top market players. In addition, future prospects for the drugs market are thoroughly studied in the research reports.
Publications found:
8,555
Sort by:
US Blood Cancer Drug Market & Pipeline Analysis 2015
US$ 3,000.00
... & Prevalence Blood Cancer Drug Market Overview Blood Cancer Drug Market Dynamics Leukemia, Lymphoma & Myeloma Drug Clinical Pipeline Insight Leukemia, Lymphoma & Myeloma Drug Clinical Pipeline: 435 Drugs Majority Drugs in Phase-I Clinical Trials: 128 Drugs Marketed Leukemia, Lymphoma & Myeloma Drug Clinical ...
July 2015
1100 pages
Global Antibody Drug Conjugate Market Outlook 2020
US$ 1,200.00
... Antibody Drug Conjugates (ADCs) in pipeline highlight the potential for new therapeutic innovations in the ADC industry. According to this edition of the report “Global Antibody Drug Conjugate Market Outlook 2020”, the ADC market is anticipated to reach around US$ 12.7 Billion by 2020. In our report, there is a detailed analysis of the market for ADCETRIS ...
June 2015
80 pages
Global Erythropoietin Market Outlook 2020
US$ 400.00
... , the global erythropoietin market is expected to scale newer heights. The latest research by RNCOS titled “Global Erythropoietin Market Outlook 2020”, unfolds the market dynamics of the erythropoietin market. In this report, the global erythropoietin industry ... global market. Our industry analysts studied all the facets of the global erythropoietin market to portray a crystal-clear picture of the current as well as the expected future market outlook ...
June 2015
45 pages
Global Microfluids Market Outlook 2020
US$ 1,500.00
... entitled “Global Microfluids Market Outlook 2020”, describes the overall microfluidics industry landscape with core emphasis on healthcare applications. According to analysis, the market for healthcare microfluidic devices was worth US$2.5 Billion in 2014 and is poised for a double digit growth during the forecasted period (2014-2020 ...
June 2015
60 pages
Global Vitamin and Supplements Market: Trends & Opportunities (2015-2019)
US$ 800.00
... titled “Global Vitamin and Supplements Market: Trends and Opportunities (2015-2019)” provides an insight into the vitamin and vitamin supplements market world-wide with focus on present market size and growth expected in the near future. The report analyzes the key vitamins – Vitamin B, Vitamin C, Vitamin ...
June 2015
70 pages
2015-2019 US Drugs of Abuse Point-of-Care Testing Market: Physician Offices, Emergency Rooms, Ambulatory Care Centers-- Supplier Shares, Sales Forecasts, Emerging Technologies, Competitive Strategies
US$ 2,000.00
... from VPGMarketResearch contains 14 tables, and provides a comprehensive analysis of thePOC drugs of abuse testing market, including trends, dynamics, size, growth, regulatory requirements ... sales forecasts for drugs of abuse procedures by market segment:- Physician Offices/Group Practices- Emergency Rooms - Ambulatory Care Centers- Analysis of drugs of abuse procedures Competitive ...
June 2015
165 pages
2015-2019 US Drugs of Abuse Decentralized/POC Testing Market: Physician Offices, Emergency Rooms, Ambulatory Care Centers-- Supplier Shares, Sales Forecasts, Emerging Technologies, Competitive Strategies
US$ 2,000.00
... from VPGMarketResearch contains 14 tables, and provides a comprehensive analysis of thePOC drugs of abuse testing market, including trends, dynamics, size, growth, regulatory requirements ... sales forecasts for drugs of abuse procedures by market segment:- Physician Offices/Group Practices- Emergency Rooms - Ambulatory Care Centers- Analysis of drugs of abuse procedures Competitive ...
June 2015
165 pages
2015-2019 European Nucleic Acid Testing/NAT Market: Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies--Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing
US$ 15,760.00
... identify and evaluate the major business opportunities emerging in the European molecular diagnostics market during the next five years. The ... business and technological trends in major European countries (France, Germany, Italy, Spain, UK); provides 5-year test volume/sales forecasts; estimates shares of leading ...
June 2015
1273 pages
2015-2019 World Nucleic Acid Testing/NAT Market: Emerging Technologies and Strategic Profiles of Leading Suppliers
US$ 2,800.00
This 180-page report provides detailed analyses of current and emerging molecular diagnostic technologies, and their potential market applications, including DNA sequencing, RNA probes, detection technologies, biochips, genosensors, microarrays, labs-on-the-chip, and other. The report also presents strategic ...
June 2015
180 pages
2015-2019 US Nucleic Acid Testing/NAT Market: Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies--Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing
US$ 7,600.00
... probe and biochip technologies, test formats, detection methodologies, trends in testing automation and amplification methods. Five-year test volume and reagent sales ... categories: - Infectious Diseases - Genetic Diseases - Cancer- Paternity Testing/HLA Typing - Forensic Testing Review of testing methodologies an instrumentation technologies. Feature comparison of automated and ...
June 2015
1157 pages
2015-2019 World Nucleic Acid Testing/NAT Market: Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies--Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing
US$ 27,600.00
... - Forensic Testing- Cancer - Paternity Testing/HLA Typing- Genetic Diseases - Others- Five-year test volume and sales projections for over 30 NAT assays. - A comprehensive ... other suppliers. - Extensive review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation and over 30 target/signal amplification methods ...
June 2015
1398 pages
2015-2019 UK Nucleic Acid Testing/NAT Market: Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies--Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing
US$ 5,360.00
... probe and biochip technologies, test formats, detection methodologies, trends in testing automation and amplification methods. Ten-year test volume and reagent sales ... categories: - Infectious Diseases- Genetic Diseases- Cancer- Paternity Testing/HLA Typing- Forensic Testing Review of testing methodologies an instrumentation technologies. Feature comparison of automated and ...
June 2015
1122 pages
Investigation Report on China Olanzapine Market, 2010-2019
US$ 2,000.00
... holergasia. Mental illness has surpassed cancer and become the biggest threat to human health, ranking first in the total burden of disease in China. As an atypical antipsychotic, olanzapine ... life brought about by China’s economic development, the incidence of mental illness and psychological problems is growing. Therefore, the market size of olanzapine in China is expected to keep expanding ...
June 2015
25 pages
Investigation Report on China Alendronate Sodium Market, 2010-2019
US$ 2,000.00
... Merck Sharp & Dohme (Italy), CSPC Ouyi Pharmaceutical Co., Ltd, Beijing Wansheng Pharmaceutical Co., Ltd, Haini Pharmaceutical Co., Ltd and Chengdu Tiantaishan Pharmaceutical Co., Ltd occupy the majority of market share, among which Merck Sharp & Dohme ...
June 2015
30 pages
Investigation Report on China Zoledronic Acid Market, 2010-2019
US$ 2,000.00
... Novartis (Switzerland), Chia Tai Tianqing Pharmaceutical Group Co., Ltd, Jiangsu Hengrui Medicine Co., Ltd, Sichuan Hairong Pharmaceutical Co., Ltd and Jilin Province Xidian Pharmaceutical Sci-Tech Development Co., Ltd occupy the majority of the market share, among which Novartis ...
June 2015
30 pages
Investigation Report on China Thymosin ?1 Market, 2010-2019
US$ 2,000.00
... Diao Group, Suzhou Tianma Pharma Group Tianji BIO-pharmaceutical Co., Ltd and Hainan Shuangcheng Pharmaceuticals Co., Ltd, among which Diao Group has the largest market share of about 36% for sales volume in 2014. However, Patheon Italia ...
June 2015
30 pages
Investigation Report on China Sodium Ibandronate Market, 2010-2019
US$ 2,000.00
... China. Currently, sodium ibandronate market in China is mainly occupied by the following companies: Science & Technology General Company Hebei Medical University, Roche Diagnostics GmbH GE), Hencer Pharmacy and Easton Pharmaceutical Co., Ltd, among which Science & Technology General Company Hebei Medical ...
June 2015
30 pages
Investigation Report on China Raloxifene Market, 2010-2019
US$ 2,000.00
... bone mass or osteoporosis while this figure is 30%-50% among women aged 60 and above. Raloxifene (raloxifene hydrochloride), a non-hormone drug against bone resorption, belongs to the second generation of selective estrogen receptor modulator (SERMs ...
June 2015
30 pages
Investigation Report on China Levofloxacin Market, 2010-2019
US$ 2,000.00
... Daiichi Sankyo Co., Ltd (Beijing), Yangtze River Pharmaceutical Group, China Resources Double Crane Pharmaceutical Co., Ltd, Santen Pharmaceutical Co., Ltd (Japan) and Zhejiang Medicine Co., Ltd. Xinchang Pharmaceutical Factory have occupied the majority of the market share, among which Daiichi Sankyo ...
June 2015
40 pages
Investigation Report on China Simvastatin Market, 2010-2019
US$ 2,000.00
... Pharmaceutical Co., Ltd, Merck Sharp & Dohme (UK), Guangzhou Nanxin Pharmaceutical Co., Ltd, Sichuan Hairong Pharmaceutical Co., Ltd and Shandong Lukang Pharmaceutical Co., Ltd occupy the majority of market, among which Hangzhou MSD Pharmaceutical Co., Ltd ...
June 2015
40 pages
Investigation Report on China Risedronate Sodium Market, 2010-2019
US$ 2,000.00
... Risedronate sodiums in the Chinese market are all produced by local enterprises represented by Kunming Jida Pharmaceutical Co., Ltd, Topfond, Yangtze River Pharmaceutical Group, Jiangsu Chiatai Qingjiang Pharmaceutical Co., Ltd and Beijing SL Pharm, among which Kunming Jida Pharmaceutical Co., Ltd ...
June 2015
30 pages
Investigation Report on China Thrombin Market, 2010-2019
US$ 2,000.00
... thrombin in the Chinese market are Changchun Guoao Pharmaceutical Co., Ltd, Biochemical Pharmaceutical Factory of Zhuhai S. E. Z., Hunan Yige Pharmaceutical Co., Ltd, Hacon Pharma and Wuxi Kaifu Pharmaceutical Co., Ltd ...
June 2015
35 pages
Investigation Report on China Piperacillin Sodium and Tazobactam Sodium Market, 2010-2019
US$ 2,000.00
... Wyeth Pharmaceutical Co., Ltd (US), Qilu Pharmaceutical Co., Ltd, North China Pharmaceutical Group Corporation, Zhejiang Anglikang Pharmaceutical Co., Ltd and United Laboratories occupy the majority of the Chinese market, among which Wyeth Pharmaceutical Co., Ltd ...
June 2015
35 pages
2015-2019 World Drugs of Abuse Testing Market: Country Forecasts, Innovative Technologies, Competitive Strategies--France, Germany, Italy, Japan, Spain, UK, US
US$ 6,800.00
... from VPGMarketResearch contains 68 tables and provides analysis of the global drug of abuse testing market, including emerging tests, technologies, instrumentation, sales forecasts ... products, such as specimen preparation devices, controls, calibrators and others. 2015 2019 World Drugs of Abuse Testing Market is a unique study designed to help current suppliers and ...
June 2015
318 pages
2015-2019 World Therapeutic Drug Monitoring (TDM) Market: Country Forecasts, Innovative Technologies, Competitive Strategies--France, Germany, Italy, Japan, Spain, UK, US
US$ 6,800.00
... from VPGMarketResearch contains 83 tables and provides analysis of the global therapeutic drug monitoring testing market, including emerging tests, technologies, instrumentation, sales forecasts ... products, such as specimen preparation devices, controls, calibrators and others. 2015 2019 World Therapeutic Drug Monitoring (TDM) Market is a unique worldwide market and technology assessment designed ...
June 2015
313 pages
2015-2019 European Therapeutic Drug Monitoring (TDM) Market: Country Forecasts, Innovative Technologies, Competitive Strategies--France, Germany, Italy, Spain, UK
US$ 5,200.00
... 291 page report from VPGMarketResearch provides a comprehensive analysis of the European therapeutic drug monitoring market, including emerging tests, technologies, instrumentation, sales forecasts, market ... products, such as specimen preparation devices, controls, calibrators and others. 2015 2019 European Therapeutic Drug Monitoring (TDM) Market is a unique market and technology assessment designed to help ...
June 2015
291 pages
2015-2019 European Drugs of Abuse Testing Market: Country Forecasts, Innovative Technologies, Competitive Strategies--France, Germany, Italy, Spain, UK
US$ 5,200.00
... 300 page report from VPGMarketResearch provides a comprehensive analysis of the European drug of abuse testing market, including emerging tests, technologies, instrumentation, sales forecasts ... products, such as specimen preparation devices, controls, calibrators and others. 2015 2019 European Drugs of Abuse Testing Market” is a unique study designed to help current suppliers and ...
June 2015
300 pages
Calming and Sleeping in South Korea
US$ 990.00
... South Korea, calming and sleeping was led by herbal/traditional calming products as not many sleeping OTC products were available. Due to its long history and ... in herbal/traditional calming products, Woo Hwang Chung Sim Won, saw current value growth of 18% in 2014. Euromonitor International's Calming and Sleeping in South Korea report offers ...
June 2015
22 pages
Investigation Report on China Bromhexine Market, 2010-2019
US$ 2,000.00
... bromhexine in the Chinese market mainly comes from local enterprises like Jiangxi Kelun Pharmaceutical Co., Ltd, Jincheng Haisi Pharmaceutical Co., Ltd and Shanxi Powerdone Pharmaceutical Co., Ltd, Shijiazhuang No.4 Pharmaceutical Co., Ltd ...
June 2015
30 pages
Investigation Report on China Entecavir Market, 2010-2019
US$ 2,000.00
... hepatitis B virus (HBV) exceeds 100 million in China, among which 20-30 million suffering from chronic Hepatitis B. ... entecavir in China rose from CNY 30 million in 2006 to CNY 1.207 billion in 2014 and CAGR during this period reached up to 55%. Entecavir made by Sino-American Shanghai Squibb Pharmaceuticals Ltd ...
June 2015
30 pages
